NeuImmune, Inc.
- Biotech or pharma, therapeutic R&D
Our vision, through the engineering of precision biologics, is to position NeuImmune as the leading glycoprotein therapeutics company focused on addressing enzyme replacement therapies associated with unmet orphan disease conditions, starting with lysosom
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}